[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].

Abstract

In 55 hepatocellular carcinoma patients treated with transcatheter arterial embolization or one shot therapy, the prognosis of patients treated with UFT (group A; n = 23) were historically compared with those of patients treated without UFT (group B; n=32). In group A, survival rate was 91.3% at 6 month; 67.5% at 1-year, 24.3% at 2-year, 24.3% at 3 year, in group B, 59.4% at 6-month, 37.5% at 1 year, 16.1% at 2-year. In these comparison, group A revealed significantly higher survival rate than group B. These results indicated that UFT was effective as maintenance therapy after transcatheter arterial embolization or one shot therapy with hepatocellular carcinoma.

Cite this paper

@article{Kitamura1990TherapyOH, title={[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].}, author={Tadaichi Kitamura and Toru Maruyama and Hirotoshi Nakamura and Kazuhiko Hayashi and Masafumi Shigehira and Yoshitaka Iwaki and Takashi Okamoto and Takashi Ishikawa and Yasuhiro Ishinoda and Hiroyuki Kisanuki}, journal={Gan to kagaku ryoho. Cancer & chemotherapy}, year={1990}, volume={17 8 Pt 1}, pages={1467-71} }